Analyst
Individual Investor
Equibles does not estimate personal net worth.
Abdul Kedar is recorded as Analyst at Individual Investor. Abdul Kedar has spoken on 1 earnings call across 1 company, most recently for Natco Pharma Limited on November 13, 2026. The companies whose calls Abdul Kedar spoke on are classified in the Healthcare sector.
“So, my first question is with regards to your quarterly run rate in India. I know that has been growing quite well. So, I wanted to understand, you know, whether it is entirely driven by semaglutide, and in terms of this Onco price cut, you know, how do we see that getting impacted on India growth ahead?”
Individual Investor
Analyst
Transcript header (unverified)
Natco Pharma Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Earnings Call for the Quarter Ended September 30, 2026
Natco Pharma Limited
